NAMS Stock Price
NewAmsterdam Pharma Company N.V.
NAMS stock price is $20.62 (+3.05% on the day), giving NewAmsterdam Pharma Company N.V. a market cap of $2.39B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
NAMS Stock Overview
- Price
- $20.62
- Previous close
- $20.01
- Open
- $20.30
- Market cap
- $2.39B
- P/E ratio
- -11.7
- 52-week range
- $20.91 - $42.20
- 1-year price target
- $51.00
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 38
About NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAMS | $20.62 | +3.0% | 868.08K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW